Chris O'Meara, Associated Press
NEW BRUNSWICK, N.J. — Johnson & Johnson says its first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales. The world's biggest maker of health care products easily beat Wall Street expectations and raised its earnings outlook.
The maker of Tylenol, medical devices and prescription drugs said Tuesday that net income was $4.73 billion, or $1.64 per share, up from $3.5 billion, or $1.22 per share, a year earlier.
Excluding one-time items, income was $4.43 billion, or $1.54 per share. Analysts surveyed by FactSet expected $1.48.
Revenue totaled $18.12 billion, up 3.5 percent. Analysts expected $18.04 billion.
The company, based in New Brunswick, N.J., raised its profit forecast for 2014 to $5.80 to $5.90 per share. In January, J&J forecast $5.75 to $5.85.
- The pimple dilemma: To pop or not to pop
- Past few days 'difficult' for former...
- Big ruling for abortion rights in Supreme...
- What to know about Supreme Court tossing...
- Getting overdose antidote with painkillers...
- Senate Democrats block GOP's Zika funding bill
- Top-ranked Jason Day skipping Rio Olympics...
- When sick, Dr. Mom sometimes has the best advice
- 45 new locations open to provide free... 38
- Big ruling for abortion rights in... 36
- Supreme Court abortion decision could... 31
- Arches Health Plan shutdown leaves $33... 30
- Family searches for answers after... 10
- Senate Democrats block GOP's Zika... 4
- 4 Utah public health clinics to expand... 4
- What every parent needs to know about... 3